Graf Akcie BIO (Bio-Rad Laboratories Inc.). Diskuze k akciím BIO. Aktuální informace BIO.

Základní informace o společnosti Bio-Rad Laboratories Inc. (Akcie BIO)

Skvělé pro velmi rychlou analýzu společnosti. Investor může porovnat různé ukazatele s konkurenčními firmami.

Tržní kapitalizace 21.52B
Hodnota podniku (EV) 22.25B
Tržby 2.88B
EBITDA 576.993M
Zisk 4.045B
Růst v tržbách Q/Q 33.35 %
Růst v tržbách Y/Y 25.56 %
P/E (Cena vůči ziskům) 5.31
Forward P/E 13.29
EV/Sales 7.73
EV/EBITDA 38.57
EV/EBIT 4.26
PEG 4.34
Price/Sales 7.47
P/FCF 36.68
Price/Book 2.18
Účetní hodnota na akcii 331.30
Hotovost na akcii 33.42
FCF vůči ceně 2.73 %
Počet zaměstnanců 8,000
Tržba na zaměstnance 359.979k
Profit margin 149.52 %
Operating margin 17.73 %
Gross margin 56.48 %
EBIT margin 181.54 %
EBITDA margin 20.04 %
EPS - Zisk na akcii 135.83
EPS - Kvartální růst 119.88 %
EPS - Očekávaný růst příští rok -18.67 %
Return on assets 29.94 %
Return on equity 39.56 %
ROIC 46.99 %
ROCE 35.98 %
Dluhy/Equity 0.31
Čistý dluh/EBITDA -5.28
Current ratio 3.90
Quick Ratio 2.88
Volatilita 2.59
Beta 0.70
RSI 36.86
Cílová cena analytiků 659
Známka akcie (dle analytiků) 1.60
Insider ownership 14.34 %
Institutional ownership 81.26 %
Počet akcií 24.704M
Procento shortovaných akcií 2.36 %
Short ratio 4.28 %
Dividenda N/A
Procentuální dividenda N/A %
Dividenda/Zisk N/A %
Obchodovaná od 1980
Země United States

Finanční výsledky akcie BIO

Finanční výsledky společnosti, napoví investorovi, zda se jedná o kvalitní společnost.

# 2020 2019 2018 2017 2016 2015
Revenue$2,545.626$2,311.659$2,289.415$2,160.153$2,068.172$2,019.441
Cost Of Goods Sold$1,107.804$1,054.663$1,066.264$972.45$929.744$897.771
Gross Profit$1,437.822$1,256.996$1,223.151$1,187.703$1,138.428$1,121.67
Research And Development Expenses$226.598$202.71$199.196$250.157$205.708$192.972
SG&A Expenses$800.267$824.625$834.783$806.79$814.697$761.99
Other Operating Income Or Expenses--$-292.513$-11.506$-62.305-
Operating Expenses$2,134.669$2,081.998$2,392.756$2,040.903$2,012.454$1,852.733
Operating Income$410.957$229.661$-103.341$119.25$55.718$166.708
Total Non-Operating Income/Expense$4,496.681$2,031.42$616$-21.445$-14.158$-20.861
Pre-Tax Income$4,907.638$2,261.081$512.659$97.805$41.56$145.847
Income Taxes$1,101.371$502.406$147.045$-24.444$15.56$36.608
Income After Taxes$3,806.267$1,758.675$365.614$122.249$26$109.239
Other Income------
Income From Continuous Operations$3,806.267$1,758.675$365.614$122.249$26$109.239
Income From Discontinued Operations------
Net Income$3,806.267$1,758.675$365.614$122.249$26$109.239
EBITDA$410.957$229.661$-103.341$119.25$55.718$166.708
EBIT$410.957$229.661$-103.341$119.25$55.718$166.708
Basic Shares Outstanding303030302929
Shares Outstanding303030303029
Basic EPS$127.86$58.93$12.25$4.12$0.88$3.74
EPS - Earnings Per Share$126.20$58.27$12.10$4.07$0.88$3.71
# 2020 2019 2018 2017 2016 2015
Current Ratio3.38832.40774.48873.93213.91354.0276
Long-term Debt / Capital0.00120.00240.09840.12920.14410.1484
Debt/Equity Ratio0.00140.07640.10930.14850.16850.1743
Gross Margin56.482154.376453.426454.982455.045155.5436
Operating Margin16.14379.9349-4.51395.52042.69418.2552
EBIT Margin16.14379.9349-4.51395.52042.69418.2552
EBITDA Margin16.14379.9349-4.51395.52042.69418.2552
Pre-Tax Profit Margin192.787197.812122.39264.52772.00957.2221
Net Profit Margin149.521976.078515.96985.65931.25715.4094
Asset Turnover0.19620.28860.4080.50550.53710.5444
Inventory Turnover Ratio1.78031.90371.82641.63491.77111.8313
Receiveable Turnover6.06935.8875.83384.6475.55445.1584
Days Sales In Receivables60.138462.001162.566978.54565.713670.7582
ROE - Return On Equity38.525230.55889.09414.1721.00814.3862
Return On Tangible Equity40.541732.90079.96925.43311.33996.1352
ROA - Return On Assets29.340821.95916.51592.8610.67522.9447
ROI - Return On Investment38.477530.48688.1993.63310.86283.7355
Book Value Per Share331.0528192.3096134.905998.376887.201584.8264
Operating Cash Flow Per Share3.90575.72555.9774-3.82090.9565-3.0498
Free Cash Flow Per Share3.88826.61755.5293-2.76750.0047-2.7098